C
Carmen L. de Hoog
Researcher at University of British Columbia
Publications - 9
Citations - 2050
Carmen L. de Hoog is an academic researcher from University of British Columbia. The author has contributed to research in topics: Effector & Type three secretion system. The author has an hindex of 8, co-authored 9 publications receiving 1974 citations. Previous affiliations of Carmen L. de Hoog include University of Southern Denmark.
Papers
More filters
Journal ArticleDOI
Unbiased quantitative proteomics of lipid rafts reveals high specificity for signaling factors
TL;DR: This work uses quantitative high-resolution MS to specifically detect proteins depleted from rafts by cholesterol-disrupting drugs, resulting in a set of 241 authentic lipid raft components, providing the first large-scale and unbiased evidence for the connection of rafts with signaling and place limits on the fraction of plasma membrane composed by rafts.
Journal ArticleDOI
A Mammalian Organelle Map by Protein Correlation Profiling
Leonard J. Foster,Carmen L. de Hoog,Carmen L. de Hoog,Yanling Zhang,Yanling Zhang,Yong Zhang,Yong Zhang,Xiaohui Xie,Vamsi K. Mootha,Vamsi K. Mootha,Matthias Mann,Matthias Mann +11 more
TL;DR: This analysis ties biochemistry, cell biology, and genomics into a common framework for organelle analysis and identifies networks of coexpressed genes, cis-regulatory motifs, and putative transcriptional regulators involved in organelle biogenesis.
Journal ArticleDOI
RNA and RNA Binding Proteins Participate in Early Stages of Cell Spreading through Spreading Initiation Centers
TL;DR: Spreading initiation centers are ribonucleoprotein complexes distinct from focal adhesions and demonstrate a role for RNA and RNA binding proteins in the initiation of cell spreading.
Journal ArticleDOI
Quantitative Proteomic Analysis of Type III Secretome of Enteropathogenic Escherichia coli Reveals an Expanded Effector Repertoire for Attaching/Effacing Bacterial Pathogens
Wanyin Deng,Hong Bing Yu,Carmen L. de Hoog,Nikolay Stoynov,Yuling Li,Leonard J. Foster,B. Brett Finlay +6 more
TL;DR: This study comprehensively characterized the type III secretome of EPEC, expanded the repertoire of type III-secreted effectors for the attaching and effacing pathogens, and provided new insights into the mode of function for LifA/Efa1/ToxB/Z4332, an important family of virulence factors.
Journal ArticleDOI
The pathogenic E. coli type III effector EspZ interacts with host CD98 and facilitates host cell prosurvival signalling
Stephanie R. Shames,Wanyin Deng,Julian A. Guttman,Carmen L. de Hoog,Yuling Li,Philip R. Hardwidge,Ho Pan Sham,Bruce A. Vallance,Leonard J. Foster,B. Brett Finlay +9 more
TL;DR: Evidence that EspZ and CD98 promote host cell survival mechanisms involving FAK during A/E pathogen infection is provided, which contributes to protection against EPEC‐mediated cytotoxicity.